• Phosbind Acrylamide in TOR Circadian Research

  2026-10-09

  This overview examines how Phosbind Acrylamide could conceptually support protein phosphorylation analysis in circadian TOR research, while separating supplier claims from the published findings of a 2025 Neurospora crassa study. The available evidence supports rhythmic TOR activity but does not establish that Phosbind was used in that study or that the reagent independently validates its conclusions.

• Modified RNA Beyond the Bench: Translational Design

  2026-10-09

  N1-Methyl-Pseudouridine-5'-Triphosphate is best understood as one variable in an integrated mRNA therapeutic system. This evidence-led perspective connects nucleotide chemistry with RNA translation mechanism research, localized delivery, and the translational lessons of a 2026 bladder cancer study while defining what remains unproven.

• Why Reporter mRNA Is a Translational Decision

  2026-10-08

  Firefly Luciferase mRNA can serve as more than a bright reporter: it can help translational teams separate delivery, RNA integrity, translation, and assay biology. This evidence-led perspective connects modified mRNA design with formulation-dependent LNP performance while defining practical boundaries for interpretation.

• CCK8s, NOX4, and ANP Secretion in Rat Atria

  2026-10-07

  Han et al. identify a signaling connection between sulfated cholecystokinin octapeptide, oxidative signaling, and atrial natriuretic peptide release in isolated beating rat atria. The study’s main contribution is a mechanistic model in which CCK-8s activates a cPLA2–arachidonic acid–NOX4–PGC-1α–PPARα/PPARγ axis, while ANP provides feedback on oxidative stress responses.

• Polymer Pen Lithography for 3D SERS Arrays

  2026-10-07

  The reference study presents polymer pen lithography as a route to ordered three-dimensional gold nanocluster arrays with tunable architecture, a reported enhancement factor of 1.67 × 10^7, and signal variation below 4.73% RSD. Its main contribution is the coupling of programmable polymer patterning with electrostatic nanoparticle assembly, although transfer to complex samples and large-scale manufacturing requires further validation.

• KR-12: From Membrane Activity to Evidence

  2026-10-06

  KR-12 is a human antimicrobial peptide fragment whose biological interpretation depends on membrane interactions, copper coordination, and assay context. This evidence-focused analysis explains what is established, what remains model-dependent, and how KR-12 (human) TFA can be positioned responsibly in peptide research.

• Dual-Readout mRNA for Translational Trafficking

  2026-10-06

  Why combining Cy5 fluorescence with firefly luciferase can help translational researchers separate mRNA delivery, intracellular fate, and productive expression—while keeping formulation-specific evidence and study limitations in view.

• Bismuth Subsalicylate: Evidence and Assay Meaning

  2026-10-05

  Bismuth Subsalicylate research is best interpreted by separating catalog-described pharmacology from validated cellular readouts. This evidence-focused guide explains how annexin V can inform, but not independently prove, apoptosis or gastrointestinal mechanisms.

• TMEM16F Lipid Scrambling in Ferroptosis

  2026-10-04

  Yang et al. identify TMEM16F-mediated plasma-membrane lipid scrambling as a late-stage suppressor of ferroptosis. The study links defective membrane remodeling to lytic death, danger-signal release, slower tumor growth, and stronger responses to PD-1 blockade, while also defining important boundaries for translating the findings.

• SUMO Protease (Ulp) Product Overview

  2026-10-03

  SUMO Protease (Ulp), SKU K1103, is a recombinant Ulp1 protease listed by APExBIO for conceptual use in removing SUMO fusion tags. No matched research paper is available for independent validation of the product claims.

• CRISPR Maps Host Genes in Brucella Infection

  2026-10-02

  A 2026 genome-wide CRISPR knockout screen in human THP-1 macrophages identified host genes that regulate Brucella invasion and intracellular survival. Validation highlighted TRAPPC2 as a particularly influential host factor, linking its loss to reduced autophagosome formation, lower bacterial persistence, reduced apoptosis, and improved macrophage viability.

• SUMO Protease (Ulp): Practical Cleavage Guide

  2026-10-01

  SUMO Protease (Ulp), SKU K1103, removes compatible SUMO fusion tags by cleaving immediately downstream of the SUMO C-terminal Gly-Gly motif during recombinant protein purification. It is intended for SUMO-tagged constructs and controlled affinity purification workflows, not for unrelated tags, nonspecific protein degradation, or unvalidated fusion architectures.

• NADH/NAD+ Redox Imbalance in Diabetic Kidney Disease

  2026-10-01

  Yan’s 2021 review frames diabetic kidney disease as a disorder in which excess NADH generation and inadequate NAD+ availability converge on mitochondrial dysfunction, oxidative stress, and impaired renal homeostasis. Its main practical contribution is an integrated pathway model that helps researchers connect glucose handling, cofactor balance, mitochondrial electron transport chain research, and potential therapeutic strategies.

• Angiotensin II Workflows for Vascular Research

  2026-09-30

  Build reproducible hypertension, vascular remodeling, and abdominal aortic aneurysm experiments with a defined Angiotensin II peptide, controlled dosing, and mechanism-focused readouts. This guide also shows how Angiotensin II–driven vascular stress can be connected cautiously to endothelial extracellular-vesicle and astrocyte assays.

• Spermine tetrahydrochloride: Applied Protocols

  2026-09-30

  Spermine tetrahydrochloride connects membrane-protection assays with protein crystallization and polyphosphazene nanoparticle workflows through charge-driven stabilization. This practical guide translates reference conditions into executable setup, optimization, troubleshooting, and carefully bounded neuroscience applications.

7945 records 2/530 page Previous Next 12345 下5页 Last page